NANO MRNA Co.,Ltd. Logo

NANO MRNA Co.,Ltd.

Biotechnology firm creating and out-licensing IP for mRNA-based therapeutics.

4571 | T

Overview

Corporate Details

ISIN(s):
JP3651120002
LEI:
Country:
Japan
Address:
港区愛宕二丁目5番1号

Description

NANO MRNA Co., Ltd. is a biotechnology firm that operates as a platform company and an IP Generator specializing in mRNA-based medicine. The company focuses on creating and out-licensing intellectual property for novel therapeutics by connecting drug discovery seeds with medical and development needs. It leverages a proprietary drug delivery system (DDS) based on micellar nanoparticle technology to advance its pipeline. Key clinical programs include an mRNA therapy for osteoarthritis (RUNX1 mRNA) and an antisense oligonucleotide (ASO) for glioblastoma (TUG1 ASO). Evolving from its predecessor, NanoCarrier, the company combines a legacy of R&D in nanoparticle technology with a strategic focus on RNA drug discovery. It also co-developed and markets Comlex®, an antibacterial agent for ear, nose, and throat conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:34
確認書
Japanese 8.2 KB
2025-11-14 07:33
半期報告書-第30期(2025/04/01-2026/03/31)
Japanese 195.4 KB
2025-10-15 08:30
訂正有価証券届出書(参照方式)
Japanese 192.3 KB
2025-10-08 09:22
有価証券届出書(参照方式)
Japanese 205.3 KB
2025-07-18 08:30
臨時報告書
Japanese 28.4 KB
2025-07-01 08:30
臨時報告書
Japanese 25.9 KB
2025-06-30 08:33
内部統制報告書-第29期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-30 08:31
確認書
Japanese 8.1 KB
2025-06-30 08:30
有価証券報告書-第29期(2024/04/01-2025/03/31)
Japanese 906.3 KB
2025-05-14 08:34
臨時報告書
Japanese 18.7 KB
2025-02-14 07:38
臨時報告書
Japanese 18.8 KB
2024-11-18 07:32
臨時報告書
Japanese 18.6 KB
2024-11-14 07:03
確認書
Japanese 8.1 KB
2024-11-14 07:02
半期報告書-第29期(2024/04/01-2025/03/31)
Japanese 169.1 KB
2024-07-01 08:07
臨時報告書
Japanese 22.2 KB

Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NANO MRNA Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.